Additionally, the PP2A regulatory subunit STRN3 negatively regulates MST1/2, and targeting the PP2A-STRN3/4 complex to reactivate the Hippo pathway was significant for inhibiting GC and enhancing chemotherapy sensitivity (Cao et al. 2024; Tang et al. 2020). Here, STRN3 is linked to gastric cancer.